Company intelligence / Profile preview

Stago

Asnières-sur-Seine, Francestago-us.com ↗

Ownership: Private
Employees: ~2600
Development stage: Commercial

Overview

Stago’s hemostasis analyzers and reagents are widely used in clinical laboratories worldwide for the diagnosis and management of bleeding and thrombotic disorders. The company’s platforms are recognized for their reliability and innovation in automating coagulation testing processes[1][6][7].

Therapeutic areas: Hematology
Modalities: DeviceReagentSoftware
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with university research teams globallypartnerships through acquisitions such as Trinity Biotech’s coagulation business.

Beyond the preview

Go deeper on Stago.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stago.

Explore the full profile